Stocks and Investing Stocks and Investing
Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022
Thu, May 26, 2022

Kevin Fischbeck Upgraded (ALHC) to Strong Buy and Decreased Target to $14 on, May 26th, 2022


Published on 2024-10-27 21:19:16 - WOPRAI, Kevin Fischbeck
  Print publication without navigation


Kevin Fischbeck of B of A Securities, Upgraded "Alignment Healthcare, Inc." (ALHC) to Strong Buy and Decreased Target from $18 to $14 on, May 26th, 2022.

Kevin has made no other calls on ALHC in the last 4 months.



There are 5 other peers that have a rating on ALHC. Out of the 5 peers that are also analyzing ALHC, 0 agree with Kevin's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Kevin


  • Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $14 on, Thursday, May 12th, 2022
  • Whit Mayo of "SVB Leerink" Initiated at Buy and Held Target at $19 on, Monday, April 4th, 2022
  • Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Decreased Target to $21 on, Monday, March 7th, 2022
  • Gary Taylor of "Cowen & Co." Maintained at Buy with Decreased Target to $11 on, Friday, March 4th, 2022
  • Jeff Garro of "Piper Sandler" Maintained at Buy with Decreased Target to $15 on, Thursday, February 24th, 2022